Your search for Crohn Disease returned 161 results

Your search for Crohn Disease returned 161 results

Sort Results:

Relevant Recent
Practice Management Information Center

Top May & June 2022 FDA Approvals

May and June 2022 FDA approvals include treatments from alopecia areata, H. pylori, Crohn disease, plaque psoriasis, and Wilson disease.
Gastroenterology Information Center

IBD Linked to 9-Fold Increased Risk for Depression

A bidirectional link between inflammatory bowel disease (IBD) and depression was found in a large cohort study; the findings extended to siblings of patients with IBD.
Dermatologic Look-Alikes

Nodules on Face

Can you diagnose the skin diseases in this Dermatologic Look-Alikes challenge?
ClinicianPOV

IL-23 Inhibitors to Improve Quality of Life in Patients With Psoriasis

The management of psoriasis revolves around injectable biologics that target T helper 17 cells-derived proinflammatory cytokines responsible for the pathogenesis of the disease. IL-23 inhibitors are injected every 8 to 12 weeks, allowing patients to have a better quality of life. Dr Joel M. Gelfand, the director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine in Philadelphia, discusses how IL-23 inhibitors filled a gap in care for patients with psoriasis.
Newsline

Help for kids with new Crohn’s disease

Early monotherapy with such anti-TNF-alpha agents as infliximabor and adalimumab may produce better overall clinical and growth outcomes.
Next post in Web Exclusives